Psychedelic Bulletin #146: Numinus Drops Lab, Consolidates Clinics; Study Suggests DMT Safe and Effective Alongside SSRI; Preprint Calls Intracellular Theory of Psychedelic-induced Neuroplasticity Into Question; A Cole Memo for Psychedelics?

This Issue: and lots more… Last week, Vancouver-based Numinus Wellness announced that it would make a number of changes that represent a broader “focus on positive cash flow generating businesses” and an effort to reduce cash expenses. CEO Payton Nyquvest said his company’s focus “on building a sustainable, cash flow positive business is paramount to our long-term success and proving the…

Source